Health Care Cost
Biosimilar noninferior to insulin glargine with lower cost in type 2 diabetes
Among adults with type 2 diabetes, biosimilar insulin was noninferior to insulin glargine for lowering HbA1c, had similar safety and cost less, although not significantly, according to data.
Adults with growth hormone deficiency have higher medical costs, more comorbidities
ATLANTA — Adults with growth hormone deficiency have higher health care costs and more comorbidities than those without growth hormone deficiency, according to findings presented at ENDO 2022.
Developing more biosimilar insulins could reduce costs for people with diabetes
NEW ORLEANS — Biosimilar products could reduce the cost of insulin for people with diabetes, but more manufacturers must enter the market to create competition and allow cost savings to be realized, according to a speaker.
Use of real-time CGM linked to lower health care costs in type 2 diabetes
The use of real-time continuous glucose monitoring is associated with a decrease in diabetes-related health care costs, according to a brief report published in Diabetes Technology & Therapeutics.
Pediatric patients with CKD, public health insurance less likely to visit physicians
GI bleeding confers worse outcomes after TAVR
Among patients who underwent transcatheter aortic valve replacement, those with gastrointestinal bleeding were more likely to die in the hospital and had higher costs and longer length of stay, researchers reported.
Economic burden of MS projected to reach $105 billion by 2039
WEST PALM BEACH, Fla. — The economic burden of MS in the United States, estimated to be more than $85 billion in 2019, is projected to rise to $105 billion by 2039, according to a study presented at ACTRIMS Forum.
Older adults with severe financial strain 61% more likely to die after acute MI
Older adults with severe financial strain had a greater risk for mortality 6 months after being discharged from the hospital for an acute myocardial infarction than those without financial strain, according to recent data.
Continuous professional development lowers health care costs
Continuous professional development for drug prescribing was associated with reduced health care costs for patients, according to findings published in JAMA Network Open.
Health care costs rise with symptom severity in patients with MDD, TRD
As symptom severity for major depressive disorder and treatment-resistant depression increases, so do costs to health systems, according to a retrospective cohort study published in the Journal of Clinical Psychiatry.